Fallback

We’re sorry, but we can’t find the page you were looking for. It’s probably something we’ve done wrong but now we know about it and we’ll try to fix it. In the meantime, try one of these options:

HOMEPAGE SHOP WEBINARS

News on Pharma Excipients

Evonik

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

13. July 2026

• Meets the growing demand for U.S.-based contract development and manufacturing organizations (CDMOs) • Further improves capabilities to handle increasing complexity of active pharmaceutical ingredients (APIs) • Important step in Evonik’s asset balancing strategy by investing in Next Generation...

Use of a hydrophilic excipient to modulate the release of dapivirine, copper ions and zinc ions from a matrix-type vaginal ring

13. July 2026

PLGA and Eudragit-based long-acting microspheres for Parkinson’s disease management

12. July 2026

A data-driven process control strategy aligned with quality by design using a local linear modelling method and fault detection & diagnosis for twin-screw granulation

12. July 2026

Fallback

News on Pharma Excipients

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

Use of a hydrophilic excipient to modulate the release of dapivirine, copper ions and zinc ions from a matrix-type vaginal ring

PLGA and Eudragit-based long-acting microspheres for Parkinson’s disease management

A data-driven process control strategy aligned with quality by design using a local linear modelling method and fault detection & diagnosis for twin-screw granulation

DFE Pharma launches Continuous Manufacturing platform to accelerate and enable formulation development

The evolution of oral biologic delivery – a Lonza Capsugel podcast episode

Recrystallization can stop nitrosamine formation in ranitidine hydrochloride

Welcome Back!

Retrieve your password